Vital Therapies INC
SEC CIK 1280776 · VTL · last insider filing 2026-06-29
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Howson Tamar D | Director | filed 2019 - 2026 |
| Bonney Michael W | Director | filed 2026 - 2026 |
| Phillips Barclay A | Director | filed 2019 - 2026 |
| Congleton Jon | Director | filed 2026 - 2026 |
| Vitt Daniel | Director · President and CEO | filed 2019 - 2026 |
| Neermann Joerg | Director | filed 2019 - 2026 |
| Rudick Richard Alan | Director | filed 2023 - 2026 |
| Skerjanec Simona | Director | filed 2024 - 2026 |
| BVF Partners L P/IL | Director | filed 2026 - 2026 |
| BVF INC/IL | Director | filed 2026 - 2026 |
| Biotechnology Value Fund II LP | Director | filed 2026 - 2026 |
| Lampert Mark N | Director | filed 2026 - 2026 |
| Biotechnology Value Trading Fund OS LP | Director | filed 2026 - 2026 |
| BVF Partners OS Ltd. | Director | filed 2026 - 2026 |
| BVF I GP LLC | Director | filed 2026 - 2026 |
| BVF II GP LLC | Director | filed 2026 - 2026 |
| BVF GP Holdings LLC | Director | filed 2026 - 2026 |
| Nagel Robert Thorvald | Director | filed 2026 - 2026 |
| Biotechnology Value Fund L P | Director | filed 2026 - 2026 |
| Nash Duane | Director · See Remarks | filed 2014 - 2025 |
| Toernsen Monika Maria | Director | filed 2022 - 2025 |
| Ossipow Vincent | Director | filed 2019 - 2022 |
| van den Bossche Jan | Director | filed 2019 - 2022 |
| Cox Russell J. | Director · Chief Executive Officer | filed 2018 - 2019 |
| Halperin Errol R. | Director | filed 2014 - 2018 |
| Bienaime Jean Jacques | Director | filed 2014 - 2018 |
| Godshall Douglas Evan | Director | filed 2014 - 2018 |
| Satter Muneer A | Director | filed 2014 - 2018 |
| Hasnain Faheem | Director | filed 2016 - 2018 |
| Cohen Cheryl | Director | filed 2015 - 2018 |
| Sears Lowell | Director | filed 2014 - 2018 |
| Millis J. Michael | Director | filed 2014 - 2018 |
| Winters Terence E. | Director · See Remarks | filed 2014 - 2017 |
| Steer Randolph C | Director | filed 2014 - 2017 |
| Croxford Philip M | Director | filed 2014 - 2017 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Whaley Glenn | PFO and PAO | filed 2020 - 2026 |
| Tardio Jason | President and COO | filed 2024 - 2026 |
| Lundgren Erik | Chief Executive Officer | filed 2026 - 2026 |
| Panzara Michael A. | Chief Medical Officer | filed 2026 - 2026 |
| Muehler Andreas | Chief Medical Officer | filed 2021 - 2025 |
| Groeppel Manfred | Chief Operating Officer | filed 2019 - 2021 |
| Patel Sanjay S | Chief Financial Officer | filed 2019 - 2019 |
| Dunn John Michael | General Counsel and Secretary | filed 2014 - 2019 |
| Ashley Robert A. | See Remarks | filed 2014 - 2019 |
| Swanson Michael V. | See Remarks | filed 2014 - 2019 |
| Stern Aron | See Remarks | filed 2014 - 2018 |
| Murawski Richard M | Vice President, Manufacturing | filed 2014 - 2018 |
| Henry Andrew | VP, Clinical Operations | filed 2014 - 2018 |
| Loewen Andrea | See Remarks | filed 2014 - 2016 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.